Astera Labs, Inc. (ALAB)

NasdaqGS • Currently up 5.12 (+1.84%) in today's trading session

1 member of Congress has disclosed 2 trades in Astera Labs, Inc. (ALAB) via STOCK Act filings. The most recent disclosure was a sale by Robert P. Bresnahan on 27 February 2025. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Astera Labs, Inc. is currently trading at $282.65, positioned at 46% of its 52-week range ($97.89 – $499.48).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$282.65
24h Change
+5.12 (+1.84%)
52 Week Range
$97.89—$499.48
View on NASDAQ

Astera Labs, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ALAB

Select to highlight on chart
2 transactions
Compliance: 100%
Robert P. Bresnahan27 Feb 202527 Mar 2025SaleStock$1,001 - $15,000N/A
Robert P. Bresnahan18 Feb 202510 Mar 2025SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$48.45B

Volume

1.8M

Beta

3.84

P/E Ratio

113.97

Fundamentals

EPS

$2.48

Div. Yield

—

Open

$283.78

Day Range

$279.79 — $289.60

Company Information

Sector
Technology
Industry
Semiconductors
Exchange
NASDAQ · USD
Country
US
CEO
Jitendra Mohan
IPO Date
2024-03-20
Website
www.asteralabs.com

Astera Labs, Inc. develops, produces, and markets semiconductor-based connectivity solutions for cloud computing and artificial intelligence infrastructure. Its core offering, the Intelligent Connectivity Platform, comprises a comprehensive portfolio...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$1.19

Rev. Est.

$550.6M

Days Until

69

Recent Quarters

Q2 20264 Aug
EPS$0.80
Beat 15.8%
Q1 20265 May
EPS$0.61
Beat 13.6%
Q4 202510 Feb
EPS$0.58
Beat 12.4%
Q3 20254 Nov
EPS$0.49
Beat 25.7%
Q2 20255 Aug
EPS$0.44
Beat 35.8%
Q1 20256 May
EPS$0.33
Beat 16.2%
Q4 202410 Feb
EPS$0.37
Beat 42.3%
Q3 20244 Nov
EPS$0.23
Beat 34.8%
Q2 20246 Aug
EPS$0.13
Beat 18.2%
Q1 20247 May
EPS$0.10
Beat 575.2%
Q4 202321 Mar
EPS$0.09
Q2 202330 Sept
EPS$-0.02
Q1 202330 Jun
EPS$-0.15
Q4 202231 Mar
EPS$-0.13
Q3 202231 Dec
EPS$-0.59
Q2 202230 Sept
EPS$-0.16
Q1 202230 Jun
EPS$-0.80
Q4 202131 Mar
EPS$-0.16

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ALAB

Which members of Congress have traded ALAB?
1 member of Congress has disclosed 2 trade in Astera Labs, Inc. (ALAB) under the STOCK Act: Robert P. Bresnahan.
When was ALAB most recently disclosed by Congress?
The most recent ALAB disclosure was a sale by Robert P. Bresnahan on 27 February 2025.
What is the total disclosed congressional trading volume for ALAB?
Members of Congress have disclosed approximately $16K in ALAB sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ALAB?
This ALAB page updates as soon as new STOCK Act disclosures are filed for Astera Labs, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.